Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Syntaxin patents

List of Syntaxin patents

List of National Steel Car patents

List of Modern Meadow patents

List of Gojo Industries patents

CEOs of bookkeeping companies

List of data center patents

Patents where

Current Assignee

Name

is

Syntaxin

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7470661 Delivery of superoxide dismutase to neuronal cells	Patent 7470661 was granted and assigned to Syntaxin on December, 2008 by the United States Patent and Trademark Office.		Syntaxin		United States Patent and Trademark Office	7470661	December 30, 2008
	‌ US Patent 8956847 Fusion proteins	Patent 8956847 was granted and assigned to Syntaxin on February, 2015 by the United States Patent and Trademark Office.	Syntaxin	Syntaxin		United States Patent and Trademark Office	8956847	February 17, 2015
	‌ US Patent 8124405 Fusion proteins	Patent 8124405 was granted and assigned to Syntaxin on February, 2012 by the United States Patent and Trademark Office.		Syntaxin		United States Patent and Trademark Office	8124405	February 28, 2012
	‌ US Patent 8481040 Carrier for targeting nerve cells	Patent 8481040 was granted and assigned to Syntaxin on July, 2013 by the United States Patent and Trademark Office.		Syntaxin		United States Patent and Trademark Office	8481040	July 9, 2013
	‌ US Patent 7892560 Clostridial toxin derivatives able to modify peripheral sensory afferent functions	Patent 7892560 was granted and assigned to Syntaxin on February, 2011 by the United States Patent and Trademark Office.		Syntaxin		United States Patent and Trademark Office	7892560	February 22, 2011
	‌ US Patent 8158132 Clostridial toxin derivatives able to modify peripheral sensory afferent functions	Patent 8158132 was granted and assigned to Syntaxin on April, 2012 by the United States Patent and Trademark Office.		Syntaxin		United States Patent and Trademark Office	8158132	April 17, 2012
	‌ US Patent 9115350 Carrier for targeting nerve cells	Patent 9115350 was granted and assigned to Syntaxin on August, 2015 by the United States Patent and Trademark Office.	Syntaxin	Syntaxin		United States Patent and Trademark Office	9115350	August 25, 2015
	‌ US Patent 8790897 Treatment of mucus hypersecretion	Patent 8790897 was granted and assigned to Syntaxin on July, 2014 by the United States Patent and Trademark Office.		Syntaxin		United States Patent and Trademark Office	8790897	July 29, 2014
	‌ US Patent 7368532 Constructs for delivery of therapeutic agents to neuronal cells	Patent 7368532 was granted and assigned to Syntaxin on May, 2008 by the United States Patent and Trademark Office.		Syntaxin		United States Patent and Trademark Office	7368532	May 6, 2008
	‌ US Patent 8796216 Suppression of neuroendocrine diseases	Patent 8796216 was granted and assigned to Syntaxin on August, 2014 by the United States Patent and Trademark Office.		Syntaxin		United States Patent and Trademark Office	8796216	August 5, 2014
	‌ US Patent 7727538 Methods and compounds for the treatment of mucus hypersecretion	Patent 7727538 was granted and assigned to Syntaxin on June, 2010 by the United States Patent and Trademark Office.		Syntaxin		United States Patent and Trademark Office	7727538	June 1, 2010
	‌ US Patent 7887810 Clostridial toxin derivatives able to modify peripheral sensory afferent functions	Patent 7887810 was granted and assigned to Syntaxin on February, 2011 by the United States Patent and Trademark Office.		Syntaxin		United States Patent and Trademark Office	7887810	February 15, 2011
	‌ US Patent 7452543 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics	Patent 7452543 was granted and assigned to Syntaxin on November, 2008 by the United States Patent and Trademark Office.		Syntaxin		United States Patent and Trademark Office	7452543	November 18, 2008
	‌ US Patent 7897158 Recombinant toxin fragments	Patent 7897158 was granted and assigned to Syntaxin on March, 2011 by the United States Patent and Trademark Office.		Syntaxin		United States Patent and Trademark Office	7897158	March 1, 2011
	‌ US Patent 8852603 Inhibition of secretion from non-neuronal cells	Patent 8852603 was granted and assigned to Syntaxin on October, 2014 by the United States Patent and Trademark Office.		Syntaxin		United States Patent and Trademark Office	8852603	October 7, 2014
	‌ US Patent 8124074 Fusion proteins	Patent 8124074 was granted and assigned to Syntaxin on February, 2012 by the United States Patent and Trademark Office.		Syntaxin		United States Patent and Trademark Office	8124074	February 28, 2012
	‌ US Patent 8372615 Fusion proteins	Patent 8372615 was granted and assigned to Syntaxin on February, 2013 by the United States Patent and Trademark Office.		Syntaxin		United States Patent and Trademark Office	8372615	February 12, 2013
	‌ US Patent 8614069 Non-cytotoxic fusion proteins comprising EGF muteins	Patent 8614069 was granted and assigned to Syntaxin on December, 2013 by the United States Patent and Trademark Office.		Syntaxin		United States Patent and Trademark Office	8614069	December 24, 2013

18 results

0 selected

18 results

0 selected